Methods: With informed parenteral consent, we included children with asthma, who attended for the first time to Allergy Department and collected data on clinical history, respiratory function and allergic sensitization. Asthma severity was classified using the GINA guide. We integreted the data into regression models to identify allergen sensitization most strongly associated with asthma severity. Results: We included 260 children with ages ranging from 3 to 18 years old (mean 11.5 6 2.85). Male/female ratio: 1.4:1. 72.3% had mild asthma; 23.8% moderate asthma and 3.8% severe asthma. Skin prick testing with aeroallergens was performed. Most of the children were sensitized to at least one aeroallergen (89.6%). Male gender and the number of positive skin tests correlated to asthma severity. Among allergic children 72.1% had more than one allergic disease. Total serum IgE did not correlate with the number of sensitizing aeroallergens, neither with asthma severity. Dust mite was the most frequent sensitization. Cat and molds were associated with a greater risk of having moderate and severe asthma. We found a progressive sensitization with age. Conclusions: Sensitization to some perennial indoor allergens, particularly cat and molds, were strongly associated with asthma severity. Inmunology and Allergolgy, Attending, Caracas, Venezuela. Background: Asthma is a multifactorial chronic inflammatory disease that presents with varying degrees of bronchospasm which can be triggered by multiple causes. One of the best known triggers is allergies, or contact with allergens that have different immunological mechanisms leading to activation of the inflammatory process characteristic of asthma. Immunoglobulin E is a protein that normally rises in the allergic process and used as a marker. Objectives: To assess the prevalence of IgE as a key factor in asthma and to estimate the incidence of non IgE-mediated asthma. Methods: 50 Patients (72% female and 28% male) aged 12 and 50 years old, diagnosed with asthma who met the inclusion and exclusion criteria, were taken from the Allergy and Immunology department. A complete medical history was performed, and the diagnosis was confirmed through a clinical history and spirometric criteria, according to GINA 2007. Subsequently, total IgE in serum were measured by electrochemiluminescence using the Cobascore equipment. Results: 72% of the patients in the study, had an elevated total IgE which suggests that this group has an allergic cause as a trigger for their disease, meanwhile the cause for the remaining patients were due to other causes. Conclusions: Evaluation of serum IgE levels should be considered in asthmatic patients in order to determine the specific etiologic treatment. Additionally, these results enhance the importance of a multidisciplinary working diagnosis, and management of this condition, considering that up to a quarter of asthma patients may have Non-IgE mediated etiology
Inmunology and Allergolgy, Attending, Caracas, Venezuela. Background: Asthma is a multifactorial chronic inflammatory disease that presents with varying degrees of bronchospasm which can be triggered by multiple causes. One of the best known triggers is allergies, or contact with allergens that have different immunological mechanisms leading to activation of the inflammatory process characteristic of asthma. Immunoglobulin E is a protein that normally rises in the allergic process and used as a marker. Objectives: To assess the prevalence of IgE as a key factor in asthma and to estimate the incidence of non IgE-mediated asthma. Methods: 50 Patients (72% female and 28% male) aged 12 and 50 years old, diagnosed with asthma who met the inclusion and exclusion criteria, were taken from the Allergy and Immunology department. A complete medical history was performed, and the diagnosis was confirmed through a clinical history and spirometric criteria, according to GINA 2007. Subsequently, total IgE in serum were measured by electrochemiluminescence using the Cobascore equipment. Results: 72% of the patients in the study, had an elevated total IgE which suggests that this group has an allergic cause as a trigger for their disease, meanwhile the cause for the remaining patients were due to other causes. Conclusions: Evaluation of serum IgE levels should be considered in asthmatic patients in order to determine the specific etiologic treatment. Additionally, these results enhance the importance of a multidisciplinary working diagnosis, and management of this condition, considering that up to a quarter of asthma patients may have Non-IgE mediated etiology 300 The Method of Antigen Specific Damage of Leucocytes by Food Additives in Patients with Bronchial Asthma Nadya Titova. Allergy, Belarussian Medical Academy of Post Graduate Education, Minsk, Belarus. Background: Diagnosis of adverse reactions to food additives is difficult due to a variety of mechanisms involved and the lack of sufficiently reliable methods for their determination. The diagnosis of intolerance to food additives is still based only on placebo-controlled oral provocation. Methods: The aim of this study was to determine the incidence of intolerance to ponceau 4R (E124), indigo carmine (E132), azorubine (E122), tartrazine (E102), sunset yellow (E110) and sodium benzoate (E211) among patients with bronchial asthma. We studied 114 patients with bronchial asthma using clinical and laboratory methods. Also we used the method of antigen specific damage of leucocytes by food additives. After the incubation of leucocytes with solutions of food additives to leucocytes was added 0.05 mL of trypan blue and counted the percentage of stained (damaged) granulocytes with the food dye and in control tests. If damaging leucocytes were more than 20% in comparison with controls -the test considered positive. Results: It was found that positive to ponceau 4R were 6 of 114 patients, to indigo carmine-3 of 73, to sodium benzoate-4 of 73, to azorubine-11 of 114, to tartrazine-7 of 114 and to sunset yellow-9 of 114. There was a correlation between the results obtained and data history. Between experienced and control group (the patients without allergic diseases) were the reliable differences (P , 0.05). Conclusions: 1. Under influence of the food additives leukocytes of patients with bronchial asthma are damaged and painted by trypan blue. 2. The method of antigen specific damage of leucocytes by food additives can be used for diagnostics of the allergies to food dyes, sodium benzoate and other gaptens. Internal Medicine, Gyeongsang University Hospital, Jinju, South Korea; 2 Internal medicine, Korea University Medical Center, Seoul, South Korea. Introduction: Ascorbic acid has been reported to have a role in the decrease of airway responsiveness in animal models. This data has been based on the regulation of airway tone and modulation of airway reactivity by ascorbic acid. Human studies show that ascorbic acid has a protective effect against the increase in bronchial responsiveness induced by ozone, and nitrogendioxide. We hypothesized that ascorbic acid may attenuate bronchial hyperresponsiveness in bronchial asthma. Methods: We studied 15 mild asthma patients and 13 healthy non smoker controls. These patients were measured plasma ascorbic acid levels with 2, 4-DNPH (dinitrophenyhydrazine) method and checked methacholine challenge with Chi method before and 1 hour after ascorbic acid intake (3 gm). To assess chronic effect of ascorbic acid on airway responsiveness, these participants were checked again plasm ascorbic acid and methacholine challenge after daily intake of ascorbic acid (1 gm) for 2 weeks. Results: There were no significant differences in plasma ascorbic acid levels in asthma patients and controls. Bronchial hyperresponsiveness was decreased after ascorbic acid intake (3 gm) in asthma patients, but not statistacally significant. This decrease was persisted with daily 1 g of ascorbic acid intake for 2 weeks. PC20FEV1 were not correlated to plasma ascorbic acid levels in asthma patients. Conclusions: In mild bronchial asthma, Airway hyperresponsiveness may be ameliorated by ascorbic acid supplementations. But further studies are necessary to address the question of the effectiveness of ascorbic acid in bronchial asthma. 
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